3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
27
Phase 3
17
Phase 1/2
10
Phase 1
9
Phase 4
2
Phase 2/3
1
Sponsor
Interventions
pembrolizumab
4
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Temozolomide
2
Specimen Handling
2
Rituximab
2
Radiotherapy
2
Radiosurgery
2
Paclitaxel
2
Neoadjuvant Therapy
2
Gemcitabine
2
Dexamethasone
2
Cisplatin
2
Carboplatin
2
venetoclax
1
theanine
1
temsirolimus
1
tafasitamab
1
sugemalimab
1
senicapoc
1
sacituzumab govitecan
1
ruxolitinib
1
perampanel
1
paricalcitol
1
pamiparib
1
olaparib
1
lutetium Lu 177 dotatate
1
irinotecan sucrosofate
1
glofitamab
1
gadobutrol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Lenalidomide
×
30 days
×
Clear all
No trials found.